JACKSONVILLE, Fla. – The United States has been dealing with a nationwide Albuterol shortage since October 2022 and it could possibly get worse before it gets better, according to doctors. Albuterol ...

Albuterol 90mcg/inh; metered-dose aerosol. <4yrs: not recommended. ≥4yrs: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise–induced bronchospasm: 2 inh 15 minutes before exercise.

A nationwide shortage of the asthma medication albuterol has been ongoing since last fall and experts fear it's only expected to get worse. Albuterol can be taken in several forms but it's the ...

LINCOLN, Neb. (KOLN) - Kohll’s Pharmacy in Lincoln is no stranger to drug shortages. First it was children’s Tylenol and Ibuprofen in December and now it’s Albuterol. The liquid form of Albuterol is ...

Credit: AstraZeneca. Airsupra combines albuterol, a short-acting beta2-agonist, and budesonide, an inhaled corticosteroid. Airsupra ® (albuterol/budesonide) is now available for the as-needed ...

LAKE FOREST, Ill. -- An ongoing shortage of a medicine commonly used to treat people with breathing problems is expected to get worse after a major supplier to US hospitals shut down last week, CNN ...

Please provide your email address to receive an email when new articles are posted on . Patients had mild asthma and uncontrolled symptoms. Doses included an albuterol-budesonide combination or ...

When it comes to providing care and filling prescriptions, it’s been a busy year for both doctors and pharmacists. “Anybody can wheeze with a given respiratory infection and we have been seeing one ...

Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla"), today announced that its wholly-owned subsidiary Cipla US is voluntarily recalling six batches of Albuterol Sulfate ...

Two drugs are better than one when it comes to stopping asthma attacks in progress, a new clinical trial has found. The study, of more than 3,100 asthma patients, found that a two-drug "rescue" ...

BRIDGEWATER, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...